(Q51095548)
Statements
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. (English)
1 reference
Kristina Gemzell-Danielsson
1 reference
Hans-Joachim Ahrendt
1 reference
Israel Nisand
1 reference
Maria Angeles Gómez
1 reference
Wolfgang Urdl
1 reference
Birgit Karskov
1 reference
Luc Oeyen
1 reference
Johannes Bitzer
1 reference
Geert Page
1 reference
Ian Milsom
1 reference
27 September 2006
1 reference
74
1 reference
6
1 reference
451-457
1 reference
Identifiers
1 reference